Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-03 Sale |
2024-09-05 4:04 pm |
Spyre Therapeutics Inc. | SYRE | Burrows Scott L Chief Financial Officer |
18,531 | $28.17 | $522,074 | 116,422 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:29 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
291 | $15.26 | $4,442 | 59,115 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 7:05 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
1,850 | $15.9 | $29,421 | 38,406 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:49 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
303 | $16.85 | $5,104 | 70,556 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
420 | $17.75 | $7,456 | 22,259 (Direct) |
View |
| 2021-12-27 Sale |
2021-12-28 5:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
12,560 | $20.07 | $252,139 | 22,679 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-15 Option Award |
2025-01-17 4:36 pm |
N/A 2035-01-15 |
Spyre Therapeutics Inc. | SYRE | Burrows Scott L Chief Financial Officer |
95,500 | $0 | 95,500 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 8:27 pm |
N/A 2034-02-01 |
Spyre Therapeutics Inc. | SYRE | Burrows Scott L Chief Financial Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2023-12-22 Option Award |
2023-12-22 6:00 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Burrows Scott L Chief Financial Officer |
134,953 | $0 | 134,953 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-05 4:10 pm |
N/A 2033-09-01 |
Aeglea BioTherapeutics Inc. | AGLE | Burrows Scott L Chief Financial Officer |
10,121,441 | $0 | 10,121,441 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:58 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
76,800 | $0 | 115,206 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-20 4:37 pm |
N/A 2029-06-11 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
5,000 | $0 | 77,533 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-20 4:37 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
5,000 | $1.6806 | 77,533 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:49 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
48,600 | $0 | 70,556 (Direct) |
View |
| 2021-12-30 Option Award |
2022-01-04 9:05 pm |
N/A 2031-08-23 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
55,704 | $0 | 55,704 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 6:50 pm |
N/A 2031-04-01 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
23,000 | $0 | 23,000 (Direct) |
View |
Ownership |
2021-04-05 6:49 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
0 | $0 | 97,012 (Direct) |
View |